Our mission is to have a meaningful impact on healthcare practices and health outcomes at a macro level. We use rigorous research methods to evaluate the implementation and impact of pharmaceutical products, medical technologies, and practices in the healthcare industry. Our team works with observational datasets and qualitative data, integrating the power of large datasets with the profound respect we have for patient voices.
Research & Evaluation
Our trained consultants are skilled in qualitative, quantitative, and mixed-methods research. We provide our clients with the following services to advance their projects:
- Targeted, structured, and systematic literature reviews
- Landscape assessments and gap analyses
- Program development and evaluation
- Protocol writing and regulatory submissions
- Quantitative, qualitative, and mixed-methods study design, data collection, and analyses
Policy Research
Our consultants draw upon our research, education, and engagement experience to provide our clients with the following services to identify processes and strategies that impact healthcare delivery to inform policy making:
- Stakeholder engagement
- Roundtable facilitation
- Regulatory support
Operations
We understand the complexities associated with conducting health services research. Our skilled consultants are available to help support our clients with their operations. We provide:
- Short-and long-term staffing support
- Expert project management support
- Assistance with developing policies and standard operating procedures that adhere to Good Clinical Practice, Good Pharmacoepidemiology Practice
- Assistance with audit preparation
- Assistance with disseminating findings including abstract submission, poster development, and manuscript preparation.
“If you want something done well and in a timely manner—Evidence to Practice is the way to go! Alecia is knowledgeable, professional, and the quality of her work is unmatched. Every task is well thought out, the highest quality, and delivered on time.”
Georgia Peeples, MPH
Program Coordinator
Reagan-Udall Foundation for the FDA
www.reaganudall.org